Mortality Outcomes and Angiotensin-Converting Enzyme Inhibitor Use in Patients With Idiopathic Pulmonary Fibrosis. Ozaltin B, Chapman R, Follet T, Vermant M, et al. Chest 2026;169:139-147.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ozaltin B, Chapman R, Follet T, Vermant M, et al. Mortality Outcomes and Angiotensin-Converting Enzyme Inhibitor Use in Patients With Idiopathic Pulmonary Fibrosis. Chest 2026;169:139-147.
PMID: 40818772